Goal Achievement After a Change to Vortioxetine in Adults With Major Depressive Disorder
NCT02972632
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
123
Enrollment
INDUSTRY
Sponsor class
Conditions
Major Depressive Disorder
Interventions
DRUG:
Vortioxetine
Sponsor
Takeda